Cargando…
Anti-NMDAR encephalitis in Crohn’s disease undergoing long-term infliximab treatment: A case report
Infliximab, a chimeric monoclonal antibody against anti-tumor necrosis factor-α (TNF-α), has revolutionized the management of inflammatory bowel disease. However, a recent nested case-control study showed that anti-TNF-α therapy exposure in patients with autoimmune diseases is associated with an inc...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659735/ https://www.ncbi.nlm.nih.gov/pubmed/36389693 http://dx.doi.org/10.3389/fimmu.2022.957575 |